348 related articles for article (PubMed ID: 2582583)
1. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
[TBL] [Abstract][Full Text] [Related]
2. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Calandra T; Baumgartner JD; Glauser MP
Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
[TBL] [Abstract][Full Text] [Related]
3. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
[TBL] [Abstract][Full Text] [Related]
4. Sequential anti-core glycolipid immunoglobulin antibody activities in patients with and without septic shock and their relation to outcome.
Nys M; Damas P; Joassin L; Lamy M
Ann Surg; 1993 Mar; 217(3):300-6. PubMed ID: 8452409
[TBL] [Abstract][Full Text] [Related]
5. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock.
Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G
J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122
[TBL] [Abstract][Full Text] [Related]
6. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
Dunn DL; Mach PA; Condie RM; Cerra FB
Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
[TBL] [Abstract][Full Text] [Related]
7. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
[TBL] [Abstract][Full Text] [Related]
8. [Protective properties of antibodies raised against conjugates of endotoxin core oligosaccharides with proteins].
Jachymek W
Postepy Hig Med Dosw; 1995; 49(1):171-8. PubMed ID: 8657614
[TBL] [Abstract][Full Text] [Related]
9. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock.
Opal SM; Scannon PJ; Vincent JL; White M; Carroll SF; Palardy JE; Parejo NA; Pribble JP; Lemke JH
J Infect Dis; 1999 Nov; 180(5):1584-9. PubMed ID: 10515819
[TBL] [Abstract][Full Text] [Related]
10. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.
Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI
N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708
[TBL] [Abstract][Full Text] [Related]
11. Immunological intervention in endotoxin shock.
Ziegler EJ
Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
[No Abstract] [Full Text] [Related]
12. Endotoxaemia in racehorses following exertion.
Baker B; Gaffin SL; Wells M; Wessels BC; Brock-Utne JG
J S Afr Vet Assoc; 1988 Jun; 59(2):63-6. PubMed ID: 3392702
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in gram-negative bacterial infections.
Lugowski C
Acta Biochim Pol; 1995; 42(1):19-24. PubMed ID: 7653155
[TBL] [Abstract][Full Text] [Related]
14. [Anti-endotoxin core glycolipid antibody: the preparation of immune serum of E. Coli J5].
Xu XN; Li ZJ; Li YP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):358-60. PubMed ID: 15182450
[TBL] [Abstract][Full Text] [Related]
15. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.
Schedel I; Dreikhausen U; Nentwig B; Höckenschnieder M; Rauthmann D; Balikcioglu S; Coldewey R; Deicher H
Crit Care Med; 1991 Sep; 19(9):1104-13. PubMed ID: 1884609
[TBL] [Abstract][Full Text] [Related]
16. [Bacterial endotoxins and their effects].
Bertók L
Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Preface.
Ronco C
Blood Purif; 2014; 37 Suppl 1():1. PubMed ID: 24457486
[No Abstract] [Full Text] [Related]
18. Anti-LPS antibodies reduce endotoxemia in whole body 60Co irradiated primates: a preliminary report.
Wells MT; Gaffin SL; Wessels BC; Brock-Utne JG; Jordaan JP; van den Ende J
Aviat Space Environ Med; 1990 Sep; 61(9):802-6. PubMed ID: 2241744
[TBL] [Abstract][Full Text] [Related]
19. Endotoxins and anti-endotoxins (their relevance to the anaesthetist and the intensive care specialist).
Brock-Utne JG; Gaffin SL
Anaesth Intensive Care; 1989 Feb; 17(1):49-55. PubMed ID: 2653093
[TBL] [Abstract][Full Text] [Related]
20. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
